Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.4K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.4K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

318
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
318
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.0K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.0K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

150
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
150
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

291
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
291
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

488
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
488

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The GALENOS approach to triangulating evidence: a structured approach for integrating information from human and animal studies.

BMC medical research methodology·2026
Same author

The nexus between anxiety and depression.

The British journal of psychiatry : the journal of mental science·2026
Same author

Breaking down the ADHD construct to build a valid diagnosis.

Acta neuropsychiatrica·2026
Same author

Lithium: challenges of being king.

The British journal of psychiatry : the journal of mental science·2026
Same author

Gordon's penchant for ginning up controversy: A fetish for argumentation?

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026
Same author

Automatically detecting trends and open questions from mental health publications: a Wellcome-funded GALENOS project.

BMJ mental health·2026
Same journal

Risk of Major Malformations Following First-Trimester Exposure to Cariprazine: Preliminary Data From the MGH National Pregnancy Registry for Psychiatric Medications.

Bipolar disorders·2026
Same journal

The Theory of Metabolic Jet Lag in Bipolar Disorder: A Pilot Feasibility Study Exploring the Association Between Eating Rhythm Disruption and Illness Burden Parameters.

Bipolar disorders·2026
Same journal

A 3-Month Follow-Up Pilot Study on Accelerated Intermittent Theta Burst Stimulation for Bipolar Depression.

Bipolar disorders·2026
Same journal

Biofluid Biomarkers of Cognitive Functioning in Bipolar Disorder: A Systematic Review by the Targeting Cognition and Older-Age Bipolar Disorder ISBD Task Forces.

Bipolar disorders·2026
Same journal

Enhancing Affective Cognitive Control in Bipolar Disorder Using Transcranial Alternating Current Stimulation: A Double-Blind, Randomized, Sham-Controlled Clinical Trial and Proof of Concept Study.

Bipolar disorders·2026
Same journal

Psychotropic Prescribing Patterns Among Bipolar-I Patients Prior to Established Bipolar-I Disorder Diagnosis.

Bipolar disorders·2026
See all related articles

Related Experiment Video

Updated: Sep 6, 2025

Identification and Quantification of Decomposition Mechanisms in Lithium-Ion Batteries; Input to Heat Flow Simulation for Modeling Thermal Runaway
11:25

Identification and Quantification of Decomposition Mechanisms in Lithium-Ion Batteries; Input to Heat Flow Simulation for Modeling Thermal Runaway

Published on: March 7, 2022

4.7K

Lithium replacement dose recommendations using Monte Carlo simulations.

Janthima Methaneethorn1,2, Zola Mannie3,4,5, Erica Bell3,4

  • 1Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand.

Bipolar Disorders
|June 29, 2022
PubMed
Summary
This summary is machine-generated.

Missing lithium doses can be managed with specific compensatory strategies. For normal kidney function, a regular dose replacement is best. For impaired kidney function, a partial dose replacement is recommended to maintain therapeutic levels.

Keywords:
LithiumMonte Carlo simulationsdelayed dosemissed dosenonadherence

More Related Videos

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

80.9K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.0K

Related Experiment Videos

Last Updated: Sep 6, 2025

Identification and Quantification of Decomposition Mechanisms in Lithium-Ion Batteries; Input to Heat Flow Simulation for Modeling Thermal Runaway
11:25

Identification and Quantification of Decomposition Mechanisms in Lithium-Ion Batteries; Input to Heat Flow Simulation for Modeling Thermal Runaway

Published on: March 7, 2022

4.7K
The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

80.9K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.0K

Area of Science:

  • Pharmacokinetics and pharmacodynamics
  • Clinical pharmacology
  • Computational modeling in medicine

Background:

  • Missed lithium doses are a frequent clinical challenge due to its narrow therapeutic window.
  • Maintaining stable lithium plasma concentrations is crucial for efficacy and safety.
  • Ethical constraints limit direct clinical studies on missed doses.

Purpose of the Study:

  • To investigate the pharmacokinetic impact of missed lithium doses.
  • To identify optimal compensatory dosing strategies for missed lithium doses.
  • To explore dosing schemes for patients with normal and impaired renal function.

Main Methods:

  • Utilized Monte Carlo simulations to model lithium concentrations under various missed dose scenarios.
  • Defined optimal dosing based on minimizing deviation from full adherence for normal renal function.
  • Selected dosing for renal impairment based on minimizing concentrations above the therapeutic upper limit (1.2 mEq/L).

Main Results:

  • The impact of a missed lithium dose is dose-dependent, with higher doses causing greater deviation.
  • For normal renal function, replacing a missed dose with a regular dose is optimal.
  • For renal impairment, replacing a missed dose with a partial dose is most suitable.

Conclusions:

  • Provided insights into optimal lithium replacement dosing schemes for different renal functions.
  • Proposed schemes can guide clinical practice and future research cautiously.
  • Emphasized the need for clinician judgment alongside proposed dosing strategies.